首页> 外文期刊>海南医科大学学报(英文版) >Clinical characteristics of 44 patients with coronavirus disease 2019 in Yongzhou
【24h】

Clinical characteristics of 44 patients with coronavirus disease 2019 in Yongzhou

机译:永州市2019年冠状病毒病44例临床特征

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To analyze the general situation and clinical characteristics of coronavirus disease 2019(COVID-2019)in Yongzhou city and provide reference for COVID-2019 control.Methods:44 patients with COVID-2019 admitted in Yongzhou central hospital were included in the study.According to the clinical classification,the patients were divided into two groups:mild and moderate group(MM group,32 cases),severe and critical group(SC group,12 cases).The general situation,epidemiology,clinical symptoms,medical history and complications,laboratory examination,imaging characteristics and treatment plan of the two groups were compared and analyzed,and the clinical characteristics,treatment process and prognosis were summarized.Results:There was no significant difference between mild and moderate group and severe and critical group in age,gender,definite incubation period or definite infection transmission generations(P=0.072,0.543,0.108,0.067).Compared with MM group,SC group needs longer hospitalization time(16.5±6.0 vs 12.4±4.5,P=0.019).There was no significant difference between the two groups in clinical symptoms of fever,cough,fatigue,pharyngeal pain,nasal obstruction,runny nose,diarrhea,history of hypertension or diabetes(each P>0.05),Compared with MM group,SC group had higher proportion of hypokalemia and AST increase(58.3%vs 15.6%,P=0.014;41.7%vs 9.4%,P=0.042).There was no significant difference in hypoproteinemia,elevated ALT,respiratory failure or heart failure(each P>0.05).Compared with MM group,SC group had higher WBC count,higher neutrophil count,lower lymphocyte count and more multileaf lesions in the laboratory and CT results(91.7%vs 37.5%,P=0.010;91.7%vs 46.9%,P=0.019;91.7%vs 18.8%,P=0.000;100.00%vs 59.4%,P=0.024).There was no significant difference between the two groups in decrease of leukocyte count,neutrophil count,eosinophil count,increase of C-reactive protein,ESR,LDH,ground glass or subpleural or extrapulmonary zone were the main pathological changes of CT(each P>0.05).Compared with MM group,SC group were different in the use rate of antibiotics,glucocorticoids,immunoglobulin and noninvasive ventilator in the treatment plan(91.7%vs 53.1%,P=0.044;100.00%vs 59.4%,P=0.024;83.3%vs 28.1%,P=0.001;41.7%vs 0,P=0.001).44 cases(100%)were cured without death.Conclusion:Compared with MM group,SC group is more likely to have increased leukocyte count,increased neutrophil count,decreased lymphocyte count and CT lesions with multileaf focus,more likely to have hypokalemia and increased AST,more likely to use antibiotics,glucocorticoids,immunoglobulins and non-invasive ventilator.
机译:目的:分析永州市冠状病毒疾病(Covid-2019)的一般情况及临床特征,为Covid-2019 Control提供参考。方法:44患者在甬州中央医院录取了一家Covid-2019。根据临床分类,患者分为两组:轻度和中度组(MM组,32例),严重和临界群(SC组,12例)。一般情况,流行病学,临床症状,病史和病史比较和分析了两组的并发症,实验室检查,成像特性和治疗计划,综述了临床特征,治疗过程和预后。结果:温和和中度群体和年龄严重和严重群体之间没有显着差异,性别,明确的潜伏期或明确的感染传输代(p = 0.072,0.543,0.108,0.067)。与MM组相比,SC组需要较长的住院科时间(16.5±6.0 vs 12.4±4.5,p = 0.019)。两组在发烧的临床症状,咳嗽,疲劳,咽部疼痛,鼻塞,流鼻涕,腹泻,高血压病史或高血压病史之间没有显着差异与MM组相比,糖尿病(每个P> 0.05),SC组的低钾血症比例较高(58.3%Vs 15.6%,P = 0.014; 41.7%Vs 9.4%,P = 0.042)。没有显着差异在冻药血症中,升高的ALT,呼吸衰竭或心力衰竭(每次P> 0.05)。与MM组,SC组有较高的WBC计数,较高的中性粒细胞计数,降低淋巴细胞计数,更高的淋巴细胞计数和更多的多叶病变,在实验室和CT结果(91.7%)(91.7%与37.5%,p = 0.010; 91.7%vs 46.9%,p = 0.019; 91.7%与18.8%,p = 0.000; 100.00%与59.4%,p = 0.024)。两组减少没有显着差异白细胞计数,中性粒细胞计数,嗜酸性粒细胞计数,C-反应蛋白的增加,ESR,LDH,地面玻璃或副外或外拷贝或外肺区是CT的主要病理变化(每个p> 0.05)。与MM组的分类,SC组在治疗计划中使用抗生素,糖皮质激素,免疫球蛋白和非侵入性呼吸机的使用率(91.7%,P = 0.044; 100.00%Vs 59.4%,p = 0.024; 83.3%vs28.1%,p = 0.001; 41.7%vs 0,p = 0.001).44案例(100%)固化而不死亡。结论:与MM组相比,SC组更可能增加白细胞增加计数,增加的中性粒细胞计数,减少淋巴细胞计数和具有多叶焦点的CT病变,更有可能具有低血症并增加AST,更有可能使用抗生素,糖皮质激素,免疫球蛋白和非侵入性呼吸机。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号